SCHEMBL19930565

SCHEMBL19930565

CC(C)CNC(=N)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
KDM4E B2RXH2 4/20 0.44
HTT P42858 2/20 0.44
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
EPHX2 P34913 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NAPRT Q6XQN6 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
ALOX12 P18054 1/20 0.40
GSK3B P49841 1/20 0.40
TOP2A P11388 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18077518 0.82 KDM4E (0.53) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL15096236 0.81 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP2C19KDM4EHTT
SCHEMBL4260290 0.79 KMT2A (0.59) ALDH1A1KDM4EHTTEPHX2SMN1; SMN2
SCHEMBL9597120 0.78 ALDH1A1 (0.42) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL6428553 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL640710 0.74 CES2 (0.50) ALDH1A1KDM4ECES2CES1SMN1; SMN2
SCHEMBL2788422 0.74 CES2 (0.50) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL31431959 0.73 ALDH1A1 (0.52) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL1459766 0.73 ALDH1A1 (0.47) ALDH1A1KDM4EHTTCES2CES1
SCHEMBL16791188 0.73 ALDH1A1 (0.52) ALDH1A1KDM4EHTTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947237-B2 Antimicrobial compounds and methods of making and using the same BioVersys AG (CH) 2021-03-16 US disclosed
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same MELINTA THERAPEUTICS, INC. 2018-03-08 US disclosed
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same MELINTA THERAPEUTICS, INC. 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same LPO, MPO, CAT ALDH1A1 1532/4885CYP1A2 1941/4885CYP2C19 1662/4885
US-10947237-B2 Antimicrobial compounds and methods of making and using the same LPO, MPO, CAT ALDH1A1 1532/4885CYP1A2 1941/4885CYP2C19 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.